Our data revealed a clear trend: reduced PER1 expression was associated with poor prognosis, while elevated PER1 expression correlated with improved overall survival ( Fig. 1 D).
← all excerpts
Circadian rhythm-related miR-6883-5p suppresses enzalutamide-resistant prostate cancer.
1
—
—